The Role of p27 in Endometrial Carcinoma
- 1 May 2001
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 81 (2) , 242-246
- https://doi.org/10.1006/gyno.2001.6144
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human CancerAnnual Review of Medicine, 1999
- Cyclin E-CDK2 is a regulator of p27Kip1.Genes & Development, 1997
- The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cellsOncogene, 1997
- Enhanced Ribosomal Association of p27Kip1 mRNA Is a Mechanism Contributing to Accumulation during Growth ArrestPublished by Elsevier ,1997
- Activation of the cell death program by inhibition of proteasome functionProceedings of the National Academy of Sciences, 1997
- Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomasNature Medicine, 1997
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Principles of CDK regulationNature, 1995